The
World health Organization has updated its guidance document on the Bacterial
Endotoxin Test. the document is available as a draft for public comment. The
document is titled:
“IMPLEMENTATION
OF THE 1 REVISED GENERAL MONOGRAPH ON PARENTERAL PREPARATIONS IN THE
INTERNATIONAL PHARMACOPOEIA: LIMITS FOR THE TEST FOR BACTERIAL ENDOTOXINS (3.4)”.
With
the document, individual monographs on injectable dosage forms in the
International
Pharmacopoeia (Ph.Int.) were investigated with a view to add a limit for bacterial
endotoxins to each monograph that currently does not include such a requirement.
The result of the review is that a number of endotoxin limits have been
proposed.
Furthermore,
in the new general monograph on Parenteral preparations the following statement
is made:
“For
powders and concentrates for injections and intravenous infusions, the amount
of the preparation to be tested and the nature and volume of the liquid in
which it is to be dissolved, suspended or diluted is specified in the individual
monograph.”
The
new guidance proposes to delete this sentence since the preparation of the
sample solution is described in Chapter 3.4 Test for bacterial endotoxins. The
text requires that samples should be dissolved or diluted in aqueous solutions
so that the final solutions do not exceed the maximum valid dilution (MVD).
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources